Acral Lentiginous Melanoma Diagnosed Using Combination of Dermoscopic and Histopathological Examination

Total Page:16

File Type:pdf, Size:1020Kb

Acral Lentiginous Melanoma Diagnosed Using Combination of Dermoscopic and Histopathological Examination Acral Lentiginous Melanoma Diagnosed using Combination of Dermoscopic and Histopathological Examination Calvin Santosa1, Ni Luh Putu Ratih Vibriyanti Karna1, A. A. Ari Agung Kayika Silayukti2, Herman Saputra3 1Dermatovenereology Department Sanglah General Public Hospital, Denpasar, Indonesia 2Dermatovenereology Department Mangunsada General Public Hospital, Badung, Indonesia 3Pathology Department Sanglah General Public Hospital, Denpasar, Indonesia Keywords: melanoma, acral lentiginous, dermoscopy, histopathology Abstract: Melanoma is a malignant tumor, which arises from melanocyte, and most commonly appears initially on the skin. Melanoma may arise also on mucosal surface even the leptomeningeal. Risk factors for melanoma could come endogenously and exogenously. Melanoma is still one of the leading causes of death by cancer in the world. Acral lentiginous melanoma (ALM) is an uncommon type of melanoma and usually diagnosed in the elderly on the extremities or nails. Clinically acral melanoma may be diagnosed as fungal infection or benign nevus lesion. Dermoscopy has helped clinician in differentiating between benign and malignant nevus lesion, hence not all cases need histopathological examination. Pathognomonic findings in melanoma lesion through dermoscopic examination may assist dermatologist in diagnosing melanoma. Main treatment for melanoma is still wide excision of the lesion and periodic monitoring post excision necessary to evaluate the risk of metastasis and mortality. 1 INTRODUCTION diagnose melanoma still requires histopathological examination, but with the discovery of dermoscopy Melanoma is a malignant tumor of melanocytes that has reduced the number of nevus lesions that do not can occur in the skin, mucosa and leptomeningeal. A show malignant features (Saida et al., 2011). clinical feature that may resemble ordinary nevus The main therapy for melanoma is surgical often makes the patient unaware of the condition excision. If there is a sign of metastasis, additional (Garbe and Bauer, 2012). Epidemiologically chemotherapy and immunotherapy should be given melanoma is more commonly found in Fitzpatrick (Saiag et al., 2007). The following case of acral skin type I and II who received excessive sun lentiginous melanoma is diagnosed using exposure. In Europe an incidence of 10-25 new combination of dermoscopy and histopathology cases per 100,000 population is found per year, examination. This case is reported due to a relatively whereas in the United States 20-30 cases per low incidence in Indonesia and to increase 100,000 people and the highest in Australia is 50-60 understanding of melanoma, diagnosis and cases per 100,000 population (Garbe and Leiter, appropriate management. 2009; Ferlay et al., 2013). In Indonesia alone the incidence vary but still very low. In RS Dr. M. Djamil Padang found 9 cases of melanoma during 2 CASE 2002-2007 (Azamris, 2011). Acral lentiginous melanoma (ALM) is a rare A 53-year-old Balinese mancame to type of cutaneous melanoma and is often diagnosed Dermatovenereology polyclinic of Mangunsada at the later stage with lesions in the palms, soles or Badung Hospital with a chief complaint of dark spot inside or around the nails. This condition tends to be on the right sole of his foot. found in African and Asian racial groups where Patient has a history oftrauma from a tree thorn 1 rarely found melanoma cases due to excessive sun year ago and the patient felt that there was a thorn exposure (Bradford et al., 2009). The way to that is embedded in his foot. Patients tried to remove 363 Santosa, C., Vibriyanti Karna, N., Silayukti, A. and Saputra, H. Acral Lentiginous Melanoma Diagnosed using Combination of Dermoscopic and Histopathological Examination. DOI: 10.5220/0008157503630367 In Proceedings of the 23rd Regional Conference of Dermatology (RCD 2018), pages 363-367 ISBN: 978-989-758-494-7 Copyright c 2021 by SCITEPRESS – Science and Technology Publications, Lda. All rights reserved RCD 2018 - The 23rd Regional Conference of Dermatology 2018 it without any help of medical personnel. About 10 lesion (red arrow Figure 1B-D) andon the ulcer months ago the patient claimed to have black spots showed blood vessel in dots form (red arrow appear on the trauma area on his right sole. Patients Figure 1 E), bluish globule (asterisk Figure 1E) and claimed no pain or itching on that area. The dark structureless area (circle Figure 1E). On the edge of spots slowly spread to the adjacent area. History of the ulcer there were mass of keratin with a previous mole on the area is denied. Patients homogeneous black spot on some foci. mentioned about awound which appear on the black Histopathological examination found epidermal spots 2 weeks before admission. The patient does layer with a picture of acanthosis accompanied by a not feel any pain on the when being touched. thick layer of keratin. There is a proliferation of Patients claimed to have never treated the atypical melanocyte cells along the basal epidermis condition since 1 year ago. History of similar with disturbed cohesion with relatively large sized condition in other location was not found. History of morphologies, vacuolized cytoplasm, bizarre malignancy is denied. History of systemic diseases nucleus, hyperchromatic, partially with prominent such as hypertension, diabetes mellitus, bleeding nucleus, and irregular nucleic membrane. These disorders are denied by the patient. History of any cells contain brownish pigmented granules (melanin). immunosuppressive conditions was denied. History Some of these cells extend along the superficial of similar disease in the patient's family is denied. dermis. Mitosis can be found. The superficial dermis History of malignancy, asthma, hypertension or layer looks degenerated and thin. At 1 focus contains diabetes mellitus in patient families is denied. necrotic areas with necrotic debris. This fit with the Currentlypatient works as a farmer and often does morphological picture of an acral-lentiginous not use any footwear during work. Patients have no melanoma. (Figure 2). habit of alcohol consumption or smoking. Based on the dermoscopic and histopathological Physical examination found the general examination, this patient was diagnosed with acral condition of the patient good. Blood pressure 120/80 lentiginous melanoma and was performed wide mmHg, pulse 84x/minute, respiratory frequency excision of the lesion with a margin of 1 cm and as 20x/minute and axillary temperature 36.4°C. deep as subcutaneous tissue. The tissue obtained General status were within normal limit. No from the excision were examined again and there enlarged lymph nodes were found. The were clear margin of the lesion. The patient later on dermatological status onthe right plantar pedis there got a skin graft from calf area to close the surgical are multiple hyperpigmentation macules, well- area. The patient was also recommended to do defined margin, sized 2x3 cm to 5x7 cm with a annual check up for the first 5 year. solitary ulcer above it with rising and regular edge, clean base, round, 1.5 cm in diameter. (Figure 1A) On the investigation using dermoscopy, there are found parallel ridge pattern on the hyperpigmented A B C D E Figure 1: (A) Hyperpigmented lesion on right sole with solitary ulcer on it. Dermoscopic pattern of the lesion (B,C,D,E). 364 Acral Lentiginous Melanoma Diagnosed using Combination of Dermoscopic and Histopathological Examination A B C D E F Figure 2: Histopathological image from the lesion suit with acral lentiginous melanoma. 3 DISCUSSION radiation; especially ultraviolet B. Chronic radiation can cause mutations and DNA damage which disrupt Melanoma is a tumor derived from melanocytes and the cell cycle. In a study that assessed the role of can be foundon skin, mucosal, eyes and brain trauma in the occurrence of ALM in areas not meningeal. Acral melanoma itself is a subtype most exposed to sunlight such as soles of the feet, hands commonly found in non-white populations. This and nails found about 13-55% of cases of ALM has subtype includes>70% melanoma in African races in a history of previous trauma, but its relation to the America as well as 50% in Asian racial groups development of melanoma is still unclear (Phan et (Ishihara et al., 2008). al., 2006). Risk factors from melanoma can be divided into Diagnosis of melanoma requires correlation of 3 categories including genetic factors, phenotypic clinical features, dermoscopy and histopathology. manifestations of genetic and environmental Clinically lesions of melanoma appear as interactions also environmental factors. Genetic asymmetrical lesions, having irregular edges, has mutations or polymorphism can increase one variety of colors, diameters greater than 5 mm and person's tendency for the development of melanoma. found growth of nodules or regression components The focus of genes associated with familial in the lesions. The sensitivity of these clinical melanoma is CDKN2A, which plays a role in coding features to diagnose melanoma can be as high as proteins p16 and p14 that function in the course of 70% if performed by an experienced dermatologist. cell cycle. In addition, variants of the melanocortin-1 The most common and typical dermoscopic features receptor gene (MC1R) were also found to increase for ALM are the presence of parallel-ridge patterns the risk of melanoma formation. Factors that are that have a specificity of 99%, sensitivity of 86% phenotypic manifestations of genetic and and a positive predictive value of 84%. The next environmental interactions are melanocytic nevus, most common pattern is the brownish-colored atypical melanocytic nevus and ephelids and lentigo pigment found in ALM in situ and invasive ALM. solaris. Environmental factors that play a role in the Another feature that can be found is a serrated formation of cutaneous melanoma are ultraviolet pattern consisting of a streak image at the edge of 365 RCD 2018 - The 23rd Regional Conference of Dermatology 2018 the tumor. Not infrequently also found ALM with and was treated with margin of 1 cm and as deep as ridge pattern accompanied by diffuse pigmentation subcutaneous tissue, with histopathological area.
Recommended publications
  • July 2020 Goal the Goal of the Residency Program Is to Develop Future Leaders in Both Research and Clinical Medicine
    Residency Training Program July 2020 Goal The goal of the Residency Program is to develop future leaders in both research and clinical medicine. Flexibility within the program allows for the acquisition of fundamental working knowledge in all subspecialties of dermatology. All residents are taught a scholarly approach to patient care, aimed at integrating clinicopathologic observation with an understanding of the basic pathophysiologic processes of normal and abnormal skin. Penn’s Residency Program consists of conferences, seminars, clinical rotations, research, and an opportunity to participate in the teaching of medical students. An extensive introduction into the department and the William D. James, M.D. Director of Residency Program clinic/patient care service is given to first-year residents. A distinguished clinical faculty and research faculty, coupled with the clinical and laboratory facilities, provides residents with comprehensive training. An appreciation of and participation in the investigative process is an integral part of our residency. Graduates frequently earn clinical or basic science fellowship appointments at universities across the country. Examples of these include: pediatric dermatology, dermatopathology, dermatologic surgery, dermatoepidemiology, postdoctoral and Clinical Educator fellowships. Additional post graduate training has occurred at the NIH and CDC. Graduates of our program populate the faculty at Harvard, Penn, Johns Hopkins, MD Anderson, Dartmouth, Penn State, Washington University, and the Universities of Washington, Pittsburgh, Vermont, South Carolina, Massachusetts, Wisconsin, and the University of California San Francisco. Additionally, some enter private practice to become pillars of community medicine. Misha A. Rosenbach, M.D. Associate Director of Residency Program History The first medical school in America, founded in 1765, was named the College of Philadelphia.
    [Show full text]
  • Acral Compound Nevus SJ Yun S Korea
    University of Pennsylvania, Founded by Ben Franklin in 1740 Disclosures Consultant for Myriad Genetics and for SciBase (might try to sell you a book, as well) Multidimensional Pathway Classification of Melanocytic Tumors WHO 4th Edition, 2018 Epidemiologic, Clinical, Histologic and Genomic Aspects of Melanoma David E. Elder, MB ChB, FRCPA University of Pennsylvania, Philadelphia, PA, USA Napa, May, 2018 3rd Edition, 2006 Malignant Melanoma • A malignant tumor of melanocytes • Not all melanomas are the same – variation in: – Epidemiology – risk factors, populations – Cell/Site of origin – Precursors – Clinical morphology – Microscopic morphology – Simulants – Genomic abnormalities Incidence of Melanoma D.M. Parkin et al. CSD/Site-Related Classification • Bastian’s CSD/Site-Related Classification (Taxonomy) of Melanoma – “The guiding principles for distinguishing taxa are genetic alterations that arise early during progression; clinical or histologic features of the primary tumor; characteristics of the host, such as age of onset, ethnicity, and skin type; and the role of environmental factors such as UV radiation.” Bastian 2015 Epithelium associated Site High UV Low UV Glabrous Mucosa Benign Acquired Spitz nevus nevus Atypical Dysplastic Spitz Borderline nevus tumor High Desmopl. Low-CSD Spitzoid Acral Mucosal Malignant CSD melanoma melanoma melanoma melanoma melanoma 105 Point mutations 103 Structural Rearrangements 2018 WHO Classification of Melanoma • Integrates Epidemiologic, Genomic, Clinical and Histopathologic Features • Assists
    [Show full text]
  • General Dermatology Practice Brochure
    Appointments Our Providers David A. Cowan, MD, FAAD We are currently accepting • Fellow, American Academy of Dermatology new patients. • Associate, American College of Call today to schedule your appointment Mohs Micrographic Surgery Monday - Friday, 8:00am to 4:30pm Rebecca G. Pomerantz, MD 1-877-661-3376 • Board Certified, American Academy of Cancellations & “No Show” Policy Dermatology If you are unable to keep your scheduled Lisa L. Ellis, MPAS, PA-C appointment, please call the office and we will • Member, American Academy of Physician be more than happy to reschedule for you. Assistants Failure to notify us at least 48 hours prior to your • Member, PA Society of Physician Assistants Medical and appointment may result in a cancellation fee. • Member, Society of Dermatology Physician Prescription Refills Assistants Surgical Refill requests are handled during normal office Sheri L. Rolewski, MSN, CRNP-BC hours when our staff has full access to medical • National Board Certification, Family Nurse Dermatology records. Refills cannot be called in on holidays, Practitioner Specialty weekends or more than twelve months after your • Member, Dermatology Nurse Association last exam. Please have your pharmacy contact our office directly. Test Results SMy Dermatology Appointment You will be notified when we receive your Date/Day _____________________________________ pathology or other test results, usually within two weeks from the date of your procedure. If you Time _________________________________________ do not hear from us within three
    [Show full text]
  • Dermatology at the Berkeley Outpatient Center
    Dermatology Berkeley Outpatient Center Overview Encompassing both medical and cosmetic dermatology, our experts at the Berkeley Outpatient Center offer a full range of diagnostic, treatment and surgical services for patients with cutaneous conditions. Surgical Dermatology • Fellowship-trained expertise in • Close coordination with Plastic Surgery Mohs micrographic surgery for at the Berkeley Outpatient Center, treatment of skin cancers including allowing for streamlined treatment for basal cell carcinomas and squamous related procedures in one location cell carcinomas, as well as treatment of • Outpatient surgery for removal of melanoma in situ with MART-1 staining benign skin growths and skin cancers Medical Dermatology - Conditions Treated/Services Offered • Acne, rosacea and related conditions • Mole/Atypical nevus/Melanoma • Sun-damaged skin surveillance • Aesthetic/Cosmetic dermatology • Non-melanoma skin cancers • Eczema and atopic dermatitis • Pigmentation disorders • HIV/AIDS-related skin conditions • Psoriasis • Lumps under the skin • Rashes • Infections of the skin (bacterial, viral, • Skin checks for patients with fungal and other) concerning lesions • Melanoma • Warts When to see a Dermatologist For more information, please call Dermatology Services at (510) 985-5200. Dermatology Services Providing integrated care in the community. Our Dermatology Team Erin Amerson, MD Drew Saylor, MD, MPH UCSF Health UCSF Health Dermatologist Dermatologic surgeon To learn more about our doctors, visit ucsfhealth.org/find_a_doctor. Office location: Berkeley Outpatient Center 3100 San Pablo Avenue Berkeley, CA 94702 (510) 985-5200 To learn more about our Berkeley Outpatient Center, Adeline St visit johnmuirhealth.com/ September 2020 berkeleyopc..
    [Show full text]
  • Optimal Management of Common Acquired Melanocytic Nevi (Moles): Current Perspectives
    Clinical, Cosmetic and Investigational Dermatology Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Optimal management of common acquired melanocytic nevi (moles): current perspectives Kabir Sardana Abstract: Although common acquired melanocytic nevi are largely benign, they are probably Payal Chakravarty one of the most common indications for cosmetic surgery encountered by dermatologists. With Khushbu Goel recent advances, noninvasive tools can largely determine the potential for malignancy, although they cannot supplant histology. Although surgical shave excision with its myriad modifications Department of Dermatology and STD, Maulana Azad Medical College and has been in vogue for decades, the lack of an adequate histological sample, the largely blind Lok Nayak Hospital, New Delhi, Delhi, nature of the procedure, and the possibility of recurrence are persisting issues. Pigment-specific India lasers were initially used in the Q-switched mode, which was based on the thermal relaxation time of the melanocyte (size 7 µm; 1 µsec), which is not the primary target in melanocytic nevus. The cluster of nevus cells (100 µm) probably lends itself to treatment with a millisecond laser rather than a nanosecond laser. Thus, normal mode pigment-specific lasers and pulsed ablative lasers (CO2/erbium [Er]:yttrium aluminum garnet [YAG]) are more suited to treat acquired melanocytic nevi. The complexities of treating this disorder can be overcome by following a structured approach by using lasers that achieve the appropriate depth to treat the three subtypes of nevi: junctional, compound, and dermal. Thus, junctional nevi respond to Q-switched/normal mode pigment lasers, where for the compound and dermal nevi, pulsed ablative laser (CO2/ Er:YAG) may be needed.
    [Show full text]
  • Dermatology Patch Allergy Testing Post Service - Information Request Form
    Dermatology Patch Allergy Testing Post Service - Information Request Form Blue Cross NC will review associated claim(s) for services rendered on the patient listed below. In order to determine benefits are available for the reported condition, please answer the questions below. If you would prefer to send medical records, relating to the condition for the dates listed you may do so. In this case, all answers must be supported by documentation in the patient's medical record. Please submit the completed form to Blue Cross NC per the Medical Record Submission instructions found on the bcbsnc.com provider site (https://www.bcbsnc.com/assets/providers/public/pdfs/submissions/how_to_submit_provider_initiated_medical_records.pdf) or if requested by Blue Cross NC via a bar-coded coversheet, please fax the form/medical records to the number noted on the bar-coded cover sheet within 7-10 days to facilitate the claim payment. This form must be filled out by the patient's physician or their designee which may be any of the following: Physician Assistant (PA), Nurse Practitioner (NP), Registered Nurse (RN), or Licensed Practical Nurse (LPN). Note: Credentials must be provided with signature or the form will be returned. PROVIDER INFORMATION Requesting Provider Information Place of Service Provider Name Facility Name Provider ID Facility ID PATIENT INFORMATION Patient Name:_____________________________ Patient DOB :_____________ Patient Account Number______________ Patient ID:______________ CLAIM INFORMATION Date(s) of Service_____________ CPT_________ Diagnosis_______ Dermatology Patch Allergy Testing - Information Request Form Page 1 of 3 CLINICAL INFORMATION Did the patient have direct skin testing (for immediate hypersensitivity) by: Percutaneous or epicutaneous (scratch, prick, or puncture)? ________________ Intradermal testing? ___________________________________ Inhalant allergy evaluation? _________________ Did the patient have patch (application) testing (most commonly used: T.R.U.E.
    [Show full text]
  • Fundamentals of Dermatology Describing Rashes and Lesions
    Dermatology for the Non-Dermatologist May 30 – June 3, 2018 - 1 - Fundamentals of Dermatology Describing Rashes and Lesions History remains ESSENTIAL to establish diagnosis – duration, treatments, prior history of skin conditions, drug use, systemic illness, etc., etc. Historical characteristics of lesions and rashes are also key elements of the description. Painful vs. painless? Pruritic? Burning sensation? Key descriptive elements – 1- definition and morphology of the lesion, 2- location and the extent of the disease. DEFINITIONS: Atrophy: Thinning of the epidermis and/or dermis causing a shiny appearance or fine wrinkling and/or depression of the skin (common causes: steroids, sudden weight gain, “stretch marks”) Bulla: Circumscribed superficial collection of fluid below or within the epidermis > 5mm (if <5mm vesicle), may be formed by the coalescence of vesicles (blister) Burrow: A linear, “threadlike” elevation of the skin, typically a few millimeters long. (scabies) Comedo: A plugged sebaceous follicle, such as closed (whitehead) & open comedones (blackhead) in acne Crust: Dried residue of serum, blood or pus (scab) Cyst: A circumscribed, usually slightly compressible, round, walled lesion, below the epidermis, may be filled with fluid or semi-solid material (sebaceous cyst, cystic acne) Dermatitis: nonspecific term for inflammation of the skin (many possible causes); may be a specific condition, e.g. atopic dermatitis Eczema: a generic term for acute or chronic inflammatory conditions of the skin. Typically appears erythematous,
    [Show full text]
  • Concepts of Sliding and Lifting Tissue Movement in Flap Reconstruction
    HOW I DO IT/BACK TO BASICS This new feature will emphasize innovative and better ways to perform dermatologic surgery procedures. This ar- ticle should be based on some evidence-based literature, but may describe the author’s experience with a particular procedure without being a typical clinical research article. The Editor will consider ideas for topics. Any author who is considering writing an article should submit the title to Ronald L. Moy, MD, Editor-in-Chief, 100 UCLA Medical Plaza, Suite 590, Los Angeles, CA 90024. Concepts of Sliding and Lifting Tissue Movement in Flap Reconstruction Timothy M. Johnson, MD,*†‡ Neil Swanson, MD,§ and Shan R. Baker, MD† Departments of *Dermatology, †Otorhinolaryngology, and ‡Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, and §Department of Dermatology and Otolaryngology, Oregon Health Sciences, Portland Oregon background. The optimal design of a skin flap requires an the answer to three predictable events that result from tissue understanding of the concepts of tissue movement. transfer: Where is the tension? Where are the final incision objective. The purpose of this manuscript was to demon- lines? Where is the redundant tissue? strate concepts of sliding and lifting tissue movement for flap conclusion. A mental exercise assessing all available recon- reconstruction. struction options should be performed for each individual pa- methods. Six similar defects located in the forehead–temple– tient and defect. Both patient and defect considerations need to eyebrow region were repaired using a different skin flap. be assessed. A thorough understanding of both anatomy and tis- results. The specific flap design for a given defect is based on sue movement is necessary for optimal skin flap reconstruction.
    [Show full text]
  • Surgical Treatment Options for Lower Eyelid Aging Joe Niamtu III, DMD
    COSMETIC TECHNIQUE Surgical Treatment Options for Lower Eyelid Aging Joe Niamtu III, DMD The lower eyelid and associated anatomy represent a complex structure that is key in facial aging and rejuvenation. There are numerous ways to address this region and some of the more common treat- ment options are discussed in this article. A review is presented of the diagnosis and popular treatment options to address the most common aspects of eyelid aging. The author has performed cosmetic lower eyelid surgery using transconjunctival blepharoplasty with skin resurfacing for the past 12 years, with pleasing results and low complications. Lower eyelid rejuvenation is one of the most commonly requested procedures in a cosmetic surgery practice. A firm understanding of the complex anatomy of this region is paramount to successful treatment. Although many methods exist for addressing this region, some techniques are more prone to postoperative complications. The author has had continued success with hundreds of patients by performing transconjunctival lower eyelid blepharoplasty with CO2 laser resurfacing, chemicalCOS peels, or skin-pinch DERM procedures. These procedures are safe, predictable, and have a place in theDo armamentarium Not of contemporary Copy cosmetic surgeons. ermatochalasis is the crepey, wrinkled, The basis of this article concerns skin aging and its loose, and sun damaged skin of the eye- surgical correction, but discussion of the periorbital fat is lids. Because age-associated changes to germane to the understanding of the aging process and its the upper face often present earlier than correction. The periorbital fat is an essential evolutionary age-associated changes to the lower face, system that serves in part to cushion the globe within its itD is not uncommon for the cosmetic surgery practitioner bony orbit.
    [Show full text]
  • Eyelid Surgery with Laser Resurfacing Around the Eyes to Erase the Bags, Excess Skin, and Wrinkles All at Once
    Meet Dr. Jennifer Reichel From The North Dr. Jennifer Reichel is the founder Take I-5 South and director of Pacific Dermatology Exit at Northgate Way (Exit 173) & Cosmetic Center. She is a board Take Northgate Way westbound ramp certified Dermatologist with Turn right at Northgate Way postgraduate advanced fellowship Turn right into parking garage just past training in Mohs Micrographic skin cancer surgery and cosmetic Meridian Ave. N. surgery. Dr. Reichel specializes in liposuction, eyelid and facial From The South rejuvenation. TakeI-5 North Dr. Reichel attended the University of Colorado for both Exit at Northgate Way (Exit 173) her undergraduate degree and her doctorate of Medicine. Turn left on 1st Avenue N. She completed medical school in 1997. She then underwent Turn left on Northgate Way residency training in Dermatology at the University of Washington followed by a postgraduate fellowship in Mohs Turn right into parking garage just past skin cancer and cosmetic surgery. Dr. Reichel trained with Meridian Ave. N. some of the best eye surgeons (occuloplastics) around the country to advance her skills in eyelid rejuvenation. Free parking is located under the building “I believe that an all encompassing approach to skin care is the key to radiant, healthy complexions. I like to combine eyelid surgery with laser resurfacing around the eyes to erase the bags, excess skin, and wrinkles all at once. Eyes are one of the most important features of the face. It is amazing how refreshed and natural your face can look Eyelid after eyelid rejuvenation.” With a passion for excellence, Dr. Reichel is dedicated to delivering custom-tailored results that are harmonious Surgery with patients’ goals and proud reflections of Pacific Dermatology & Cosmetic Center.
    [Show full text]
  • Acral Melanoma
    Accepted Date : 07-Jul-2015 Article type : Original Article The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma Running head: Dermoscopy of acral melanoma Word count: 3138, Tables: 6, Figures: 6 A. Lallas,1 A. Kyrgidis,1 H. Koga,2 E. Moscarella,1 P. Tschandl,3 Z. Apalla,4 A. Di Stefani,5 D. Ioannides,2 H. Kittler,4 K. Kobayashi,6,7 E. Lazaridou,2 C. Longo,1 A. Phan,8 T. Saida,3 M. Tanaka,6 L. Thomas,8 I. Zalaudek,9 G. Argenziano.10 Article 1. Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy 2. Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan 3. Department of Dermatology, Division of General Dermatology, Medical University, Vienna, Austria 4. First Department of Dermatology, Medical School, Aristotle University, Thessaloniki, Greece 5. Division of Dermatology, Complesso Integrato Columbus, Rome, Italy 6. Department of Dermatology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan 7. Kobayashi Clinic, Tokyo, Japan 8. Department of Dermatology, Claude Bernard - Lyon 1 University, Centre Hospitalier Lyon-Sud, Pierre Bénite, France. 9. Department of Dermatology and Venereology, Medical University, Graz, Austria 10. Dermatology Unit, Second University of Naples, Naples, Italy. This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as Accepted doi: 10.1111/bjd.14045 This article is protected by copyright. All rights reserved. Please address all correspondence to: Aimilios Lallas, MD.
    [Show full text]
  • Dermatopathology Laboratory
    Dermatology Dermatopathology Laboratory Dermatopathology is an essential DERMATOPATHOLOGY TESTING SerVICES component for correct diagnosis and treat- Skin biopsy review ment of skin disorders. Our laboratory offers Professional dermatopathology laboratory services comprehensive microscopic diagnosis for Technical dermatopathology laboratory services nail, hair and skin conditions. Our team con- Consultative review (second opinion) of pathology slides sists of four Board Certified Dermatologists Special stains and Dermatopathologists, Anneli R. Bowen, Immunohistochemistry (extensive list of antibodies) M.D., Keith L. Duffy, M.D., Scott R. Florell, M.D., and David A. Wada, M.D., all of whom ENhaNCED CUStomer SerVICES are trained in clinical dermatology and evaluate patients at the University of Utah Timely reporting Health Care Dermatology Clinics in addition Local courier services and prepaid expedited shipping to interpreting dermatopathology speci- Complimentary test request forms, biopsy fixatives and shipping supplies mens. Their expertise covers a wide range of Laboratory services billing department neoplastic and inflammatory skin diseases. Extensive participating insurance list CONTACT US Our Dermatopathology Laboratory Client Services Office is open from 8 a.m. - 5 p.m., Mountain Time, Monday – Friday. We will return all calls and inquires received after business hours the next business day. Dermatopathology LABoratory Department of Dermatology, University of Utah Health Care 30 North 1900 East, 4A330 SOM, Salt Lake City, Utah 84132 Phone: (801) 585-0221 Toll-Free: 1-844-988-7284 (1-844-9UU-PATH) University of Utah Dermatopathology Laboratory participates Fax: (801) 581-6484 in the College of American Pathologists (CAP) Laboratory Email: [email protected] Accreditation Program and has Clinical Laboratory Improvement Amendments (CLIA) certification through the Centers for dermatopathology.uofumedicine.org Medicare & Medicaid Services (CMS).
    [Show full text]